Cannabis product -- Labeling and child-resistant packaging.
Checkout our iOS App for a better way to browser and research.
(1) For any cannabis product that a cannabis processing facility processes or produces and for any raw cannabis that the facility packages, the facility shall:
(a) label the cannabis or cannabis product with a label that:
(i) clearly and unambiguously states that the cannabis product or package contains cannabis;
(ii) clearly displays the amount of total composite tetrahydrocannabinol and cannabidiol in the labeled container;
(iii) has a unique identification number that:
(A) is connected to the inventory control system; and
(B) identifies the unique cannabis product manufacturing process the cannabis processing facility used to manufacture the cannabis product;
(iv) identifies the cannabinoid extraction process that the cannabis processing facility used to create the cannabis product;
(v) does not display an image, word, or phrase that the facility knows or should know appeals to children; and
(vi) discloses each active or potentially active ingredient, in order of prominence, and possible allergen; and
(b) package the raw cannabis or cannabis product in a medicinal dosage form in a container that:
(i) is tamper evident and tamper resistant;
(ii) does not appeal to children;
(iii) does not mimic a candy container;
(iv) complies with child-resistant effectiveness standards that the United States Consumer Product Safety Commission establishes; and
(v) includes a warning label that states:
(A) for a container labeled before July 1, 2021, "WARNING: Cannabis has intoxicating effects and may be addictive. Do not operate a vehicle or machinery under its influence. KEEP OUT OF REACH OF CHILDREN. This product is for medical use only. Use only as directed by a qualified medical provider."; or
(B) for a container labeled on or after July 1, 2021, "WARNING: Cannabis has intoxicating effects and may be addictive. Do not operate a vehicle or machinery under its influence. KEEP OUT OF REACH OF CHILDREN. This product is for medical use only. Use only as directed by a recommending medical provider.".
(2) For any cannabis or cannabis product that the cannabis processing facility processes into a gelatinous cube, gelatinous rectangular cuboid, or lozenge in a cube or rectangular cuboid shape, the facility shall:
(a) ensure that the label described in Subsection (1)(a) does not contain a photograph or other image of the content of the container; and
(b) include on the label described in Subsection (1)(a) a warning about the risks of over-consumption.
(3) For any cannabis product that contains any derivative cannabinoid or synthetic cannabinoid, the cannabis processing facility shall ensure that the label clearly identifies each derivative cannabinoid or synthetic cannabinoid.
(4) The department shall make rules in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act to establish:
(a) a standard labeling format that:
(i) complies with the requirements of this section; and
(ii) ensures inclusion of a pharmacy label; and
(b) additional requirements on packaging for cannabis and cannabis products to ensure safety and product quality.